Alembic Pharmaceuticals gets USFDA nod for eye drug

Alembic Pharmaceuticals Ltd today announced that the company has received approval from the US Food & Drug Administration (USFDA) to sell a generic alternative to Novartis Pharmaceuticals’ allergic conjunctivitis treatment Patanol Ophthalmic Solution. This is first ophthalmic dosage form approval for Alembic pharmaceuticals Limited. The...

Jaguar Land Rover November retail sales down 8%

Jaguar Land Rover reported an 8% decline in its November retail sales, reflecting what the premium auto-maker called “continuing challenging market conditions in China”. Sales in China were down 50.7% as “market conditions remain difficult with continuing consumer uncertainty following tariff changes and trade concerns.”...

Maruti Suzuki car prices to increase next month

Maruti Suzuki, India’s largest car maker, said it will increase car prices next month due to increased costs. “Over the past year, the cost of company’s vehicles has been impacted adversely due to increase in commodity prices and foreign exchange rates, etc. “Hence, it has...

Alembic gets USFDA approval for generic heart drug

Alembic Pharmaceuticals said it has received approval from the US Food & Drug Administration (USFDA) to sell a generic version of ANI Pharmaceuticals’ hypertension drug Atacand Tablets. Atacand had an estimated market size of US$ 22 million for twelve months ending December 2017 in the US...